FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2741555156> ?p ?o ?g. }

• W2741555156 abstract "Glioblastoma (GBM) is a highly malignant and lethal cancer of the central nervous system. Despite intensive research efforts, there has been limited progress in improving patient outcome. The current therapy for GBM patients includes surgical resection, radiotherapy and cytotoxic chemotherapy with temozolomide (TMZ), conferring a median survival time of only 14.6 months. Failure to generate more effective treatment strategies is due in part to the cellular heterogeneity within GBM tumors, which comprise a sub-population of GBM cancer stem cells (GSCs) characterized by self-renewal characteristics and resistance to TMZ. Recent work, including our own, has demonstrated that levels of the gap junction protein Connexin43 (Cx43) correlate with GBM TMZ resistance. Increased Cx43 levels occur in GSCs compared to parental GBM cells, and patients with high levels of Cx43 mRNA and low levels of MGMT, an enzyme that repairs TMZ-induced DNA lesions, have a significantly shorter life span. In contrast, Cx43 has also been associated with anti-proliferative effects in glioma and reduced levels of Cx43 protein are reported in high-grade gliomas. In addition to forming gap junctions, Cx43 can regulate cell proliferation, migration, and apoptosis, through distinct channel-independent mechanisms. Therefore, altering the localization and/or activity of Cx43 rather than Cx43 expression alone may represent a more targeted strategy in GBM treatment. Using super-resolution microscopy, we find intracellular Cx43 decorating microtubules in GSCs demonstrating for the first time such clustering in situ. Regulation of Cx43 function is primarily associated with multiple sites for post-translational modification and protein-protein interaction within the Cx43 carboxy-terminus (CT) which includes a tubulin binding domain. We have developed a peptide named JM2 (juxtamembrane 2) composed of the Cx43 CT amino acids encompassing the microtubule-binding sequence fused to an antennapedia cell penetration domain for cellular uptake. Super-resolution microscopy and biochemical analysis confirm JM2 specific interaction with microtubules concomitantly with a loss of Cx43 interaction with microtubules in GSCs derived from patient tumors. In addition, we observe that JM2 decreases Cx43 gap junction plaque formation and cell-cell communication in GSCs and limits microtubule dynamics. Importantly, JM2 decreases cell survival in TMZ-resistant GSCs and GSC neurosphere formation in vitro, and GSC-derived tumor growth in vivo. Our current research includes the development of JM2-loaded biodegradable nanoparticles for sustained JM2 delivery in preparation for future clinical trials. In conclusion, we have developed a Cx43 mimetic peptide that significantly decreases the tumorigenic potential of GSCs and represents a novel and potent therapeutic opportunity to alter Cx43 activity in targeting chemoresistant GSCs for GBM treatment. Citation Format: Samy Lamouille, James W. Smyth, Laurie O9Rourke, Pratik Kanabur, Sujuan Guo, Jane Jourdan, Zhi Sheng, Robert G. Gourdie. Targeting glioblastoma cancer stem cells with a novel Connexin43 mimetic peptide [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4765. doi:10.1158/1538-7445.AM2017-4765" @default.
• W2741555156 created "2017-08-08" @default.
• W2741555156 creator A5016255536 @default.
• W2741555156 creator A5034717131 @default.
• W2741555156 creator A5034962714 @default.
• W2741555156 creator A5040428803 @default.
• W2741555156 creator A5050056546 @default.
• W2741555156 creator A5070967294 @default.
• W2741555156 creator A5072247924 @default.
• W2741555156 creator A5073168183 @default.
• W2741555156 date "2017-07-01" @default.
• W2741555156 modified "2023-09-23" @default.
• W2741555156 title "Abstract 4765: Targeting glioblastoma cancer stem cells with a novel Connexin43 mimetic peptide" @default.
• W2741555156 doi "https://doi.org/10.1158/1538-7445.am2017-4765" @default.
• W2741555156 hasPublicationYear "2017" @default.
• W2741555156 type Work @default.
• W2741555156 sameAs 2741555156 @default.
• W2741555156 citedByCount "1" @default.
• W2741555156 countsByYear W27415551562021 @default.
• W2741555156 crossrefType "proceedings-article" @default.
• W2741555156 hasAuthorship W2741555156A5016255536 @default.
• W2741555156 hasAuthorship W2741555156A5034717131 @default.
• W2741555156 hasAuthorship W2741555156A5034962714 @default.
• W2741555156 hasAuthorship W2741555156A5040428803 @default.
• W2741555156 hasAuthorship W2741555156A5050056546 @default.
• W2741555156 hasAuthorship W2741555156A5070967294 @default.
• W2741555156 hasAuthorship W2741555156A5072247924 @default.
• W2741555156 hasAuthorship W2741555156A5073168183 @default.
• W2741555156 hasBestOaLocation W27415551561 @default.
• W2741555156 hasConcept C121608353 @default.
• W2741555156 hasConcept C126322002 @default.
• W2741555156 hasConcept C2777389519 @default.
• W2741555156 hasConcept C2778227246 @default.
• W2741555156 hasConcept C28328180 @default.
• W2741555156 hasConcept C2908647359 @default.
• W2741555156 hasConcept C502942594 @default.
• W2741555156 hasConcept C509974204 @default.
• W2741555156 hasConcept C55427017 @default.
• W2741555156 hasConcept C71924100 @default.
• W2741555156 hasConcept C86803240 @default.
• W2741555156 hasConcept C95444343 @default.
• W2741555156 hasConcept C96232424 @default.
• W2741555156 hasConcept C99454951 @default.
• W2741555156 hasConceptScore W2741555156C121608353 @default.
• W2741555156 hasConceptScore W2741555156C126322002 @default.
• W2741555156 hasConceptScore W2741555156C2777389519 @default.
• W2741555156 hasConceptScore W2741555156C2778227246 @default.
• W2741555156 hasConceptScore W2741555156C28328180 @default.
• W2741555156 hasConceptScore W2741555156C2908647359 @default.
• W2741555156 hasConceptScore W2741555156C502942594 @default.
• W2741555156 hasConceptScore W2741555156C509974204 @default.
• W2741555156 hasConceptScore W2741555156C55427017 @default.
• W2741555156 hasConceptScore W2741555156C71924100 @default.
• W2741555156 hasConceptScore W2741555156C86803240 @default.
• W2741555156 hasConceptScore W2741555156C95444343 @default.
• W2741555156 hasConceptScore W2741555156C96232424 @default.
• W2741555156 hasConceptScore W2741555156C99454951 @default.
• W2741555156 hasLocation W27415551561 @default.
• W2741555156 hasOpenAccess W2741555156 @default.
• W2741555156 hasPrimaryLocation W27415551561 @default.
• W2741555156 hasRelatedWork W1965389466 @default.
• W2741555156 hasRelatedWork W2090547813 @default.
• W2741555156 hasRelatedWork W2091824023 @default.
• W2741555156 hasRelatedWork W2296551054 @default.
• W2741555156 hasRelatedWork W2326678604 @default.
• W2741555156 hasRelatedWork W2328703119 @default.
• W2741555156 hasRelatedWork W2402520623 @default.
• W2741555156 hasRelatedWork W2497540900 @default.
• W2741555156 hasRelatedWork W2561928441 @default.
• W2741555156 hasRelatedWork W2586761827 @default.
• W2741555156 hasRelatedWork W2615902603 @default.
• W2741555156 hasRelatedWork W2938599512 @default.
• W2741555156 hasRelatedWork W2944201754 @default.
• W2741555156 hasRelatedWork W2970937984 @default.
• W2741555156 hasRelatedWork W2983249298 @default.
• W2741555156 hasRelatedWork W3037208368 @default.
• W2741555156 hasRelatedWork W3111284893 @default.
• W2741555156 hasRelatedWork W3165476786 @default.
• W2741555156 hasRelatedWork W3174777946 @default.
• W2741555156 hasRelatedWork W3179382370 @default.
• W2741555156 isParatext "false" @default.
• W2741555156 isRetracted "false" @default.
• W2741555156 magId "2741555156" @default.
• W2741555156 workType "article" @default.